Ubs Group Ag Icad Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Icad Inc stock. As of the latest transaction made, Ubs Group Ag holds 2,800 shares of ICAD stock, worth $5,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,800

Previous 2 139900.0%

Holding current value

$5,460

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.19 - $1.74 $3,329 - $4,868	2,798 Added 139900.0%	2,800 $4,000
Q2 2024 Aug 13, 2024	BUY	$1.28 - $1.9 $2 - $3	2 New	2 $0
Q3 2023 Nov 09, 2023	SELL	$1.8 - $3.61 $17,524 - $35,146	-9,736 Reduced 99.96%	4 $0
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.63 $11,103 - $15,876	9,740 New	9,740 $15,000
Q2 2022 Aug 10, 2022	SELL	$3.02 - $4.56 $100,306 - $151,455	-33,214 Reduced 99.7%	100 $0
Q1 2022 May 16, 2022	SELL	$3.92 - $7.48 $76,549 - $146,069	-19,528 Reduced 36.96%	33,314 $149,000
Q4 2021 Feb 14, 2022	BUY	$6.7 - $11.38 $78,403 - $133,168	11,702 Added 28.44%	52,842 $381,000
Q3 2021 Nov 15, 2021	BUY	$10.11 - $17.56 $62,631 - $108,784	6,195 Added 17.73%	41,140 $442,000
Q2 2021 Aug 13, 2021	SELL	$14.9 - $20.82 $161,769 - $226,042	-10,857 Reduced 23.7%	34,945 $605,000
Q1 2021 May 12, 2021	SELL	$12.57 - $21.22 $159,299 - $268,921	-12,673 Reduced 21.67%	45,802 $972,000
Q4 2020 Feb 11, 2021	SELL	$8.73 - $14.56 $67,447 - $112,490	-7,726 Reduced 11.67%	58,475 $772,000
Q3 2020 Nov 12, 2020	BUY	$8.56 - $11.6 $335,303 - $454,383	39,171 Added 144.92%	66,201 $583,000
Q2 2020 Jul 31, 2020	BUY	$6.63 - $12.85 $179,208 - $347,335	27,030 New	27,030 $270,000
Q1 2020 May 01, 2020	SELL	$6.94 - $14.42 $11,194 - $23,259	-1,613 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.23 - $7.98 $1,545 - $1,979	-248 Reduced 13.33%	1,613 $13,000
Q3 2019 Nov 14, 2019	SELL	$5.62 - $7.86 $7,109 - $9,942	-1,265 Reduced 40.47%	1,861 $13,000
Q2 2019 Aug 14, 2019	BUY	$4.53 - $7.0 $13,254 - $20,482	2,926 Added 1463.0%	3,126 $20,000
Q1 2019 May 14, 2019	SELL	$3.65 - $6.05 $7,781 - $12,898	-2,132 Reduced 91.42%	200 $1,000
Q4 2018 Feb 14, 2019	SELL	$2.54 - $4.34 $8,567 - $14,638	-3,373 Reduced 59.12%	2,332 $8,000
Q3 2018 Nov 14, 2018	BUY	$2.85 - $3.19 $8,561 - $9,582	3,004 Added 111.22%	5,705 $16,000
Q2 2018 Aug 14, 2018	BUY	$3.04 - $3.93 $860 - $1,112	283 Added 11.7%	2,701 $8,000
Q1 2018 May 15, 2018	SELL	$2.96 - $4.0 $3,318 - $4,484	-1,121 Reduced 31.68%	2,418 $7,000
Q4 2017 Feb 14, 2018	BUY	$3.38 - $4.74 $8,206 - $11,508	2,428 Added 218.54%	3,539 $12,000
Q3 2017 Nov 14, 2017	SELL	$3.3 - $4.42 $4,468 - $5,984	-1,354 Reduced 54.93%	1,111 $5,000
Q2 2017 Aug 14, 2017	SELL	N/A	-305 Reduced 11.01%	2,465 $11,000
Q1 2017 Nov 14, 2017	BUY	N/A	2,770	2,770 $13,000

Others Institutions Holding ICAD

# of Institutions

Shares Held

5.45M

Call Options Held

3.6K

Put Options Held

14.6K

View Full List

About ICAD INC

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $49.4M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

More about ICAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account